Should You Add Comerica Stock to Your Portfolio This Month?

NYSE: CMA | Comerica Incorporated News, Ratings, and Charts

CMA – Shares of Comerica (CMA) have been slumping so far this year, despite multiple benchmark interest rate hikes. As the commercial bank’s spreads increase due to the monetary tightening policies, is CMA an ideal investment now? Let’s find out.

With $89.20 million in total assets (as of March 31, 2022), Comerica Incorporated (CMA) offers financial products and services. It operates through four segments: Commercial Bank; Retail Bank; Wealth Management; and Finance. Since March 2022, CMA has been focused on the structural transformation of its business to improve customer service and streamline its small business focus. CMA plans to consolidate 22 of its existing 432 U.S. locations across three of its retail markets by September this year.

Rising interest rates bode well for commercial banks, as they charge higher interest on loans to customers. However, given consumer spending has been decelerating over the past month amid inflationary pressures, as retail sales declined marginally in May. This, coupled with rising borrowing costs, could discourage lending in the upcoming months, adversely impacting CMA’s loan and interest income. Shares of CMA have declined 17.1% year-to-date.

Here’s what could shape CMA’s performance in the near term:

Bleak Financials

CMA’s interest and fees on loan income declined marginally year-over-year to $383 million in the fiscal first quarter ended March 31, 2022. Total noninterest income fell 9.6% from the same period last year to $244 million. Net income came in at $189 million, reflecting a 46% decline from the prior-year quarter. In addition, the comprehensive loss amounted to $772 million, compared to the $181 income reported in the same period last year. EPS declined 43.6% from the prior-year quarter to $1.37.

Moreover, CMA’s net operating cash outflow stood at $710 million, compared to the $159 million inflow in the prior-year quarter. Cash and cash equivalents came in at $13.55 billion as of March 31, 2022, down 8.9% from March 31, 2021. In addition, loan yields declined four basis points in the fiscal first quarter, while average deposits decreased by $5.4 billion.

Poor Growth Story

CMA’s revenues declined at a 2.4% CAGR over the past three years, while EBITDA fell at a rate of 9.1% per annum over this period. Trailing-12-month EBIT fell 2% year-over-year. The company’s net income and EPS declined 8% and 1.9% per year over the past three years. Furthermore, CMA’s total assets declined at a 4% CAGR over the past three years and a 3.8% rate over the past five years.

Over the trailing 12 months, the company’s total assets fell 15.7% year-over-year. Levered free cash flow declined at 3.6% per annum over the past three years. Over the past year, levered free cash flow fell 14.4% year-over-year.

Stretched Valuation

In terms of forward non-GAAP P/E, CMA is currently trading at 10.16x, 3.9% higher than the industry average of 9.78. Its trailing-12-month PEG multiple of 0.67 is 114.8% higher than the industry average of 0.31.

In addition, CMA is currently trading 3.03 times its forward sales, 7.6% higher than the industry average of 2.82. Also, its forward Price/Book ratio of 1.39 is 29.7% higher than the industry average of 1.07.

POWR Ratings Reflect Bleak Prospects

CMA has an overall D rating, which equates to Sell in our proprietary POWR Ratings system. The POWR Ratings are calculated considering 118 distinct factors, with each factor weighted to an optimal degree.

CMA has a grade of D for Quality and Growth. The company’s trailing-12-month ROA of 1.13% is 9.9% lower than the industry average of 1.25%, justifying the Quality grade. In addition, CMA’s revenues and net income have declined at rates of 2.4% and 8% per annum over the past three years, in sync with the Growth grade.

Of the 11 stocks in the F-rated Money Center Banks industry, CMA is ranked last.

Beyond what I’ve stated above, view CMA ratings for Sentiment, Stability, Momentum, and Value here.

Bottom Line

The Fed hiked the benchmark interest rates by 75 basis points yesterday, the largest hike in nearly three decades. However, analysts expect CMA’s EPS to decline 24.5% year-over-year in the fiscal second quarter (ending June) and 10% year-over-year in fiscal 2022. As the Fed is slated to maintain its aggressive stance amid persistent macroeconomic issues, CMA is best avoided now.

CMA shares were trading at $73.81 per share on Thursday afternoon, down $2.53 (-3.31%). Year-to-date, CMA has declined -13.72%, versus a -22.53% rise in the benchmark S&P 500 index during the same period.

About the Author: Aditi Ganguly

Aditi is an experienced content developer and financial writer who is passionate about helping investors understand the do’s and don'ts of investing. She has a keen interest in the stock market and has a fundamental approach when analyzing equities. More...

More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
CMAGet RatingGet RatingGet Rating

Most Popular Stories on

:  |  News, Ratings, and Charts

Is the Bear Market Over???

The S&P 500 (SPY) quickly dispensed with 2 key levels of resistance on Wednesday following statements by Fed Chairman Powell. Now more people are contemplating that the 2022 bear market may be over and time to get more bullish. 40 year investment veteran Steve Reitmeister weighs in on this timely topic in his new commentary. Spoiler Alert: he is not impressed and still believes that the bears have the upper hand. Read on below for the full story...

:  |  News, Ratings, and Charts

1 Momentum Stock to Buy Now for Extraordinary Gains in 2023

Valero Energy (VLO) expanded its production for the fourth quarter anticipating increased demand. The stock is up nearly 70% in 2022. It is trading above its 50-day and 200-day moving averages. As this momentum is expected to remain, investors should consider buying VLO for continued gains in 2023. Read on…

:  |  News, Ratings, and Charts

3 Stocks Every Investor Should Add to Their Watchlist This Week

With significant growth registered in the third quarter, investor confidence has been uplifted. Hence, quality stocks with solid growth prospects, such as Amgen (AMGN), Cognizant Technology Solutions (CTSH), and Dole plc (DOLE), could be added to the watchlist this week. Read on…

:  |  News, Ratings, and Charts

1 Stable Stock Warren Buffett Owns and You Should Too

World-famous investor Warren Buffett picked up shares of healthcare services provider McKesson Corporation (MCK) this year. The company has raised its dividends for 16 consecutive years. With a recession expected next year, this healthcare services stock is expected to remain stable as demand for healthcare and related services usually remain unaffected regardless of economic conditions. Thus, investors may consider buying the stock now. Read more…

:  |  News, Ratings, and Charts

3 Stocks Every Investor Should Add to Their Watchlist This Week

With significant growth registered in the third quarter, investor confidence has been uplifted. Hence, quality stocks with solid growth prospects, such as Amgen (AMGN), Cognizant Technology Solutions (CTSH), and Dole plc (DOLE), could be added to the watchlist this week. Read on…

Read More Stories

More Comerica Incorporated (CMA) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All CMA News